HCP engagement starts with the right data—and physician-level data (PLD) is the powerhouse behind smarter segmentation and campaign optimization. Whether you're just getting started or leveling up, our guide has you covered.
HCP engagement starts with the right data—and physician-level data (PLD) is the powerhouse behind smarter segmentation and campaign optimization. Whether you're just getting started or leveling up, our guide has you covered.
Challenge
A leading pharmaceutical company and its agency were looking for a more advanced way to improve their Connected TV (CTV) campaign aimed at patients with moderate to-severe ulcerative colitis (UC). Their previous audience strategy hadn’t worked well—it failed to reach enough of the right patients and instead attracted too much irrelevant data, which weakened the campaign’s overall impact.
With over 900,000 people in the U.S. affected by UC—often diagnosed between the ages of 15 and 35—hitting a higher percentage of clinically relevant healthcare consumers should have been more achievable, especially given that nearly 30% of those in remission experience a recurrence within a year.
To overcome these challenges, the client turned to OptimizeRx, for a more precise and privacy-safe audience solution with their chosen media activation partner, Madhive.
The results were clear – OptimizeRx delivered measurable improvement in audience quality.
OptimizeRx delivered a privacy-safe and clinically accurate audience at scale, surpassing national benchmarks for Audience Quality. Since ulcerative colitis (UC) is influenced by many factors and has no known direct cause, it was crucial for the brand to cut through the noise and reach the patients who truly needed care.
To do this, we used our patented Micro-Neighborhood® targeting technology to pinpoint high-value, hyperlocal areas where eligible patients actually live. With these precise locations identified, we built custom audience segments using the company’s extensive database of medical diagnosis (Dx) and pharmacy (Rx) claims.